Psych drugs Flashcards
anxiety, trauma, stressor related disorders- classes of drugs
- benzos
- atypical anxiolytic/nonbarbituate anxiolytic
- selective serotonin reuptake inhibitors (SSRI antidepressants)
benzo drugs
- alpralzolam
- diazepam
- chlordiazepoxide
- clorazepate
- oxazepam
- clonazepam
benzo moa
-enhances the inhibitory effects of gaba
benzo use
- anxiety
- seizure disorders
- insomnia
- muscle spasm
- alcohol withdrawal
- induction of anesthesia
- amnesic prior to surgery/procedures
- used for short term due to potential for dependence
benzo complications
- cns depression
- anterograde amnesia
- oral toxicity: drowsiness, lethargy, confusion
- iv toxicity: resp. depression, hypotension, cardiac/resp. arrest
- withdrawal effects: anxiety, insomnia, diaphoresis, tremors, lightheadedness, delirium, htn, muscle twitching, and seizure
benzo caution/contraindications
- pregnancy risk
- contraindicated in sleep apnea, resp. depression, glaucoma
- caution in elderly and liver disease
benzo interactions
- cns depressants
- grapefruit juice
benzo implications
- antidote for oral toxicity is gastric lavage followed by activated charcoal
- admin flumazenil for both types of toxicity
- administer at bedtime if possible due to sedation
benzo education
- avoid activities that require alertness
- avoid alcohol
- withdrawal effects are not common for short term use
- if taken regularly and in high doses taper off over several weeks
- store in a secure place to prevent misuse by others
atypical anxiolytic/nonbarbituate anxiolytic drug
buspirone
atypical anxiolytic/nonbarbituate anxiolytic moa
- unknown
- dependency less likely
- doesn’t cause sedation or potentiate effects of other cns depressants
- initial response takes a week, full effects takes 2-4 weeks, not for acute use
atypical anxiolytic/nonbarbituate anxiolytic complications
- dizziness (self-limiting)
- constipation
- suicidal ideation
atypical anxiolytic/nonbarbituate anxiolytic contraindications
concurrent use with MAOIs or for 14 days after d/c MAOIs
atypical anxiolytic/nonbarbituate anxiolytic interactions
st john’s wort (herbals)
atypical anxiolytic/nonbarbituate anxiolytic education
- effects dont occur immediately
- take on a regular basis, not prn
- tolerance, dependence, withdrawal are not an issue
selective serotonin reuptake inhibitors (SSRI) drugs
- paroxetine: prototype for anxiety
- sertraline
- citalopram
- escitalopram
- fluoxetine: prototype for depression
- fluvoxamine
SSRI moa
ANXIETY
-inhibits serotonin reuptake allowing more serotonin to stay at the junction of the neuron
-long half life
-up to 4 weeks to produce therapeutic effects
DEPRESSION
-blocks reuptake of monoamines, intensifying effects of serotonin
-first line treatment for depression
-takes 1-3 weeks or longer for effects
SSRI uses
- anxiety
- depression
SSRI complications
- weight changes (weight loss early, followed by weight gain)
- gi bleeding
- hyponatremia
- serotonin syndrome (hallucination, fever, seizures, hyper/hypotension)
- bruixism
- withdrawal syndrome
- postural hypotension
- suicidal ideation
- rash: specific for fluoxetine
SSRI complications specific to paroxetine
- early: nausea, diaphoresis, tremor, fatigue, drowsiness
- late: sexual dysfunction! (impotence, delayed or absent orgasm, delayed or absent ejaculation, decreased sexual interest)
SSRI education
- report problems with sexual function
- report ae to the provider (may need to change dose/med)
- pregnancy risk, except for paroxetine
SSRI implications
- monitor for serotonin syndrome, usually occurs 2-72 hours after initiation of treatment
- taper off slowly
- effectiveness noted with improved mood
depressive disorders- drug classes
- SSRIs
- serotonin-norepinephrine reuptake inhibitors
- atypical antidepressants
- tricyclic antidepressants
- monoamine oxidase inhibitors (MAOIs)
serotonin-norepinephrine reuptake inhibitors drugs
- venlafaxine, prototype
- desvenlafaxine
- duloxetine
- levomilnacipran
serotonin-norepinephrine reuptake inhibitors moa
blocks reuptake of norepinephrine and serotonin
serotonin-norepinephrine reuptake inhibitors indications
- major depression
- pain due to fibromyalgia, osteoarthritis, diabetic neuropathy
serotonin-norepinephrine reuptake inhibitors complications
- htn, tachycardia
- withdrawal syndrome
- sexual dysfunction
serotonin-norepinephrine reuptake inhibitors contraindications/precautions
- pregnancy risk, avoid in third trimester, can cause infant to have withdrawal syndrome
- contraindicated in concurrent use with SSRIs, MAOIs, or TCAs
- taper off slowly
serotonin-norepinephrine reuptake inhibitors interactions
- etoh
- john worts
atypical antidepressants drugs
- bupropion, prototype
- vilazodone
- mirtazapine
- nefazodone
- trazodone ER
atypical antidepressants ae
- headache
- dry mouth
- n/v
- weight loss
- anorexia
- seizures, dont admit to those at risk for seizures